In vivo studies of a peptidomimetic that targets EGFR dimerization in NSCLC is a research paper published in Journal of Cancer (2020). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R15 CA188225
National Institutes of Health
Grant: 1R15CA188225-01A1
Molecular mechanism of EGFR heterodimerization: inhibition by a peptidomimetic
FWCI
0.31
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals